Literature DB >> 17438338

Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis.

Anissa Fergani1, Hugues Oudart, Jose-Luis Gonzalez De Aguilar, Bastien Fricker, Frédérique René, Jean-François Hocquette, Vincent Meininger, Luc Dupuis, Jean-Philippe Loeffler.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common adult motor neuron disease, causing motor neuron degeneration, muscle atrophy, paralysis, and death. Despite this degenerative process, a stable hypermetabolic state has been observed in a large subset of patients. Mice expressing a mutant form of Cu/Zn-superoxide dismutase (mSOD1 mice) constitute an animal model of ALS that, like patients, exhibits unexpectedly increased energy expenditure. Counterbalancing for this increase with a high-fat diet extends lifespan and prevents motor neuron loss. Here, we investigated whether lipid metabolism is defective in this animal model. Hepatic lipid metabolism was roughly normal, whereas gastrointestinal absorption of lipids as well as peripheral clearance of triglyceride-rich lipoproteins were markedly increased, leading to decreased postprandial lipidemia. This defect was corrected by the high-fat regimen that typically induces neuroprotection in these animals. Together, our findings show that energy metabolism in mSOD1 mice shifts toward an increase in the peripheral use of lipids. This metabolic shift probably accounts for the protective effect of dietary lipids in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438338      PMCID: PMC1974855          DOI: 10.1194/jlr.M700017-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.

Authors:  A M Clement; M D Nguyen; E A Roberts; M L Garcia; S Boillée; M Rule; A P McMahon; W Doucette; D Siwek; R J Ferrante; R H Brown; J-P Julien; L S B Goldstein; D W Cleveland
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

Review 2.  Amyotrophic lateral sclerosis: all roads lead to Rome.

Authors:  Jose-Luis Gonzalez de Aguilar; Andoni Echaniz-Laguna; Anissa Fergani; Frédérique René; Vincent Meininger; Jean-Philippe Loeffler; Luc Dupuis
Journal:  J Neurochem       Date:  2007-01-23       Impact factor: 5.372

3.  Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation.

Authors:  J N Fain; N A Del Mar ; C A Meade; A Reiner; D Goldowitz
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

4.  Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis.

Authors:  S Vielhaber; K Winkler; E Kirches; D Kunz; M Büchner; H Feistner; C E Elger; A C Ludolph; M W Riepe; W S Kunz
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

5.  Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.

Authors:  Hiroaki Yagyu; E Peer Lutz; Yuko Kako; Steven Marks; Yunying Hu; Sungshin Y Choi; Andre Bensadoun; Ira J Goldberg
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

6.  Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.

Authors:  J C Desport; P M Preux; L Magy; Y Boirie; J M Vallat; B Beaufrère; P Couratier
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

7.  Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.

Authors:  Wenzhen Duan; Zhihong Guo; Haiyang Jiang; Melvin Ware; Xiao-Jiang Li; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

8.  Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis.

Authors:  Luc Dupuis; Franck di Scala; Frédérique Rene; Marc de Tapia; Hugues Oudart; Pierre-François Pradat; Vincent Meininger; Jean-Philippe Loeffler
Journal:  FASEB J       Date:  2003-09-18       Impact factor: 5.191

Review 9.  The enzymes, regulation, and genetics of bile acid synthesis.

Authors:  David W Russell
Journal:  Annu Rev Biochem       Date:  2003-01-16       Impact factor: 23.643

Review 10.  Gastrointestinal dysfunction in amyotrophic lateral sclerosis.

Authors:  M Toepfer; C Folwaczny; A Klauser; R L Riepl; W Müller-Felber; D Pongratz
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  1999-12
View more
  53 in total

1.  Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference?

Authors:  Ji Won Yang; Sung-Min Kim; Hee-Juang Kim; Jee-Eun Kim; Kyung Seok Park; Seung-Hyun Kim; Kwang-Woo Lee; Jung-Joon Sung
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

2.  Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.

Authors:  M A Lim; M A Selak; Z Xiang; D Krainc; R L Neve; B C Kraemer; J L Watts; R G Kalb
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

3.  Glucose homeostasis in two degrees of sepsis lethality induced by caecum ligation and puncture in mice.

Authors:  Francielle B D Ferreira; Cristiane Dos Santos; Maciel A Bruxel; Everson A Nunes; Fernando Spiller; Alex Rafacho
Journal:  Int J Exp Pathol       Date:  2017-12-11       Impact factor: 1.925

4.  Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Jing Deng; Matthew Jaffa; Merit E Cudkowicz; Anne-Marie Wills
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

5.  Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling.

Authors:  Gopalakrishnan Natarajan; Curtis Perriotte-Olson; Fatema Bhinderwala; Robert Powers; Cyrus V Desouza; Geoffrey A Talmon; Jiang Yuhang; Matthew C Zimmerman; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Transl Res       Date:  2017-08-15       Impact factor: 7.012

6.  Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.

Authors:  Barkha P Patel; Adeel Safdar; Sandeep Raha; Mark A Tarnopolsky; Mazen J Hamadeh
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

7.  Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis.

Authors:  Séverine Deforges; Julien Branchu; Olivier Biondi; Clément Grondard; Claude Pariset; Sylvie Lécolle; Philippe Lopes; Pierre-Paul Vidal; Christophe Chanoine; Frédéric Charbonnier
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

8.  Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.

Authors:  Carola Stribl; Aladin Samara; Dietrich Trümbach; Regina Peis; Manuela Neumann; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Birgit Rathkolb; Eckhard Wolf; Johannes Beckers; Marion Horsch; Frauke Neff; Elisabeth Kremmer; Sebastian Koob; Andreas S Reichert; Wolfgang Hans; Jan Rozman; Martin Klingenspor; Michaela Aichler; Axel Karl Walch; Lore Becker; Thomas Klopstock; Lisa Glasl; Sabine M Hölter; Wolfgang Wurst; Thomas Floss
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

9.  Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.

Authors:  Xiaowei W Su; Wint Nandar; Elizabeth B Neely; Zachary Simmons; James R Connor
Journal:  Muscle Nerve       Date:  2016-05-19       Impact factor: 3.217

10.  Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons.

Authors:  Luc Dupuis; Jose-Luis Gonzalez de Aguilar; Andoni Echaniz-Laguna; Judith Eschbach; Frédérique Rene; Hugues Oudart; Benoit Halter; Caroline Huze; Laurent Schaeffer; Frédéric Bouillaud; Jean-Philippe Loeffler
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.